Furthermore, they observed that silencing of ANRIL in PC cell lines inhibited their proliferation, migration, and invasion, and reduced resistance to the gemcitabine-based chemotherapy, while the treatment with miR-181a reversed these effects. The gene discussed is CDKN2B-AS1; the disease is pachyonychia congenita.